LIVE WEBINAR
Monday, July 7th | 10am ET
Duration: 1 hour
Can't make the live date? Register and we'll send you a link to the recording. ​

In pharmaceutical development, where most therapies never reach the market, early and strategic data investments can make all the difference. Teams are often challenged by minimal budgets and limited visibility into the real-world treatment landscape - especially in therapeutic areas where the organization has limited prior experience or knowledge.

In this webinar, GSK shares how their team transformed early development by using claims data to reduce risk, uncover real-world treatment dynamics, and improve evidence generation ahead of launch. You'll hear how they shifted from data scarcity to insight-driven decision making - improving alignment across clinical, medical, and commercial functions. Key takeaways will include:

• How GSK modernized early-stage evidence generation with real-world claims data
• Strategies for securing budget and cross-functional buy-in
• Practical “levers for success” you can apply within your own teams

SPEAKERS

Chris Bell
​Senior Director, US Speciality, Value Evidence & Outcomes
GSK
 

Jamie Drenocky
Director, US Specialty, New Product Strategy
GSK
 

Sheila Natarajan
Director, Real World Analytics
GSK